TNF and rheumatoid arthritis: Similarly, meta-analyses have suggested either that the three anti-TNF therapies are either equally effective in RA (Hochberg et al., 2003; Spofu et al., 2005) or that there are modest benefits in favor of etanercept compared with infliximab (Reynolds and Bacon, 2002) or adalimumab (Reynolds and Bacon, 2003).